Surgery for degenerative mitral valve disease
BMJ 2010; 341 doi: https://doi.org/10.1136/bmj.c5339 (Published 12 November 2010) Cite this as: BMJ 2010;341:c5339- Norman Briffa, consultant cardiothoracic surgeon
- 1Chesterman Wing, Northern General Hospital, Sheffield S5 7AU, UK
- norman.briffa{at}sth.nhs.uk
Mitral valve prolapse is the most common cause of mitral regurgitation requiring surgical correction in Western Europe and the United States.1 This condition is characterised by the accumulation of glycosaminoglycans in leaflet tissue and the appearance of billowing thickened leaflets on echocardiography.2 Although mitral valve prolapse (also called floppy mitral valve or Barlow’s syndrome) occurs in 4-6% of the population, only a small proportion of these people develop severe mitral valve regurgitation requiring intervention. People at risk include those over 50 years and patients with severe valvular regurgitation, atrial fibrillation, and greater thickening of leaflets.2 Without treatment severe mitral regurgitation leads to deterioration of left ventricular function, pulmonary hypertension, and premature death⇓.1
The aim of surgery is to …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.